Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

ENETS Abstract Search

#4469 Therapeutic strategy for pancreatic neuroendocrine tumours: An overview of the TNE West Network (2016-2024)

Introduction: Neuroendocrine tumours (NETs) are relatively rare and often diagnosed at an advanced stage, typically occurring between the ages of 40 and 60. They primarily manifest in the gastrointestinal system, pancreas, bronchi, lungs, thymus, and thyroid.

Conference:

Presenting Author: Bengueddach A

Authors: Bengueddache A, Kehili H, Tidjane A, Tabeti B, Manouni C,

Keywords: neuroendocrine tumour, metastasis, somatostatin analogue, pancreas,

#3945 8-year follow-up reveals therapeutic approaches for patients with neuroendocrine neoplasms – Findings from the TNE West Network: 2016-2023

Introduction: Neuroendocrine tumors (NETs) are relatively rare and often diagnosed late, typically occurring between the ages of 40 and 60. They primarily manifest in the gastrointestinal system, pancreas, bronchi, lungs, thymus, and thyroid.

Conference:

Presenting Author:

Authors: Bengueddach A, Kehili H, Tidjane A, Benaoum A, Khalifa S,

Keywords: neuroendocrine tumor, metastasis, somatostatin analogues,

#3607 Artificial intelligence and management of gastroenteropancreatic neuroendocrine neoplasms

Introduction: Neuroendocrine neoplasms and the role of artificial intelligence, and management of the gastrointestinal system.

Conference:

Presenting Author:

Authors: Bengueddache A, Ke H, Tidjane A, Bengueddach A, Boudjnane N,

Keywords: IA, neuroendocrine tumor,

#3606 FOLFOX in pancreatic G1 and G2 neuroendocrine tumors

Introduction: Aim of this study: The chemotherapy of metastatic pancreatic neuroendocrine tumors (TNEm) of low grade (G1, G2 Ki-67< 20%) is based on old studies and relies on streptozocin, the tolerance of which is poor. We wanted to evaluate the efficacy of the combination 5 FU + oxaliplatin (FOLFOX) in patients with TNEp.

Conference:

Presenting Author:

Authors: Bengueddache A, Kehili H, Tidjane A, Remini A, Boudjnane N,

Keywords: FOLFOX, metastatic pancreatic neuroendocrine tumor,